Highly activated cytotoxic CD16+ T cells developing in COVID-19 have been shown recently to contribute to microvascular endothelial cell injury and release of mediators which attract neutrophils and monocytes during COVID-19 [85]. This evidence concerns the gene FCGR3A and COVID-19.